Jim Lundy will join a panel of in-house and law firm legal professionals to discuss ethical issues from the perspectives of attorneys representing firms and individuals in a hypothetical regulatory internal investigation. The panel will be moderated by a Managing Director & Counsel with Credit Suisse Securities and includes a Senior Director & Associate General Counsel with CME Group, a Managing Director & Associate General Counsel with Deutsche Bank Securities, and two partners with national law firms. To register for the event, click here.
People
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.